Skip to main content
OpenTrials
Completed

NCT Number: NCT02081144

Texting to Promote Tobacco Abstinence in Emergency Department Smokers: A Pilot Study

This is a pilot study to test the feasibility of conducting a text based smoking cessation trial with Emergency Department patients who are smokers.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Smoking Behavior Tobacco Abstinence

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1

Primary location

Yale New Haven Hospital

New Haven, Connecticut, 06510, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 years or older
  • have smoked >= 100 cigarettes lifetime
  • describe themselves as every or some day smokers
  • are able to give written informed consent
  • reside in Connecticut
  • own a cell phone with texting capability.

Exclusion criteria

  • inability to read or understand English
  • currently receiving formal tobacco dependence treatment
  • current use of tobacco cessation products (patch, gum, inhaler, nasal spray, lozenge, e-cigarette)
  • currently using Zyban (bupropion), Wellbutrin (bupropion) or Chantix (varenicline) for smoking cessation
  • current suicide or homicide risk
  • current psychotic disorder
  • life-threatening or unstable medical or psychiatric condition
  • does not have phone with CT area code and with texting capability
  • lacks capacity to give informed consent
  • leaving the ED against medical advice
  • pregnant, nursing, or trying to conceive
  • incarcerated
  • resides in an extended care facility

Treatment and study plan

Smokefree TXT Program

Other

The SmokeFreeTxt program is a library consisting of ~130 brief messages that can be proactively sent to smokers' cellphones using software developed and maintained by NCI. The message content is informed by principles of cognitive behavioral therapy. They are sent to smokers at random times of day (during normal waking hours), up to 5 messages per day.

nicotine replacement patches

Drug

Subject will be given 4 weeks of Nicotine Replacement Patches, based on the amount he/she is smoking at baseline.

Nicotine Replacement Gum

Drug

Subjects will be given 10 pieces of 2mg Nicotine Replacement Gum x 28 days.

Faxed Referral CT Smokers Quitline

Behavioral

A faxed referral will be sent to the CT Smokers Quitline for the subject.

Primary outcomes

  1. Survey of satisfaction and usage of Smokefree TXT Program

    Time frame: 1 month post enrollment

    Study team will develop a survey to assess both subjects' satisfaction with the Smokefree TXT Program and ease of use.

Secondary outcomes

  1. 7 day point prevalence abstinence

    Time frame: 1 month post enrollment

    7 day point prevalence abstinence will be assessed by asking if the subject has smoked even a puff in the past 7 days.

Sponsors and collaborators

Lead sponsor

Yale University

Other

Collaborators

  • National Cancer Institute (NCI)
  • National Institutes of Health (NIH)

Registry information

Important dates

Study start
2014
Primary completion
2014
Study completion
2014
First posted
Mar 7, 2014
Registry last updated
Mar 5, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.